Randomisation and masking
Eligible participants were randomly assigned (21:21:2:2:8) to five treatment groups (moxidectin and albendazole, ivermectin and albendazole, albendazole, ivermectin, or moxidectin) using a computer-generated randomisation code by order of arrival to treatment, resulting in a minimum block size of 54. Two levels of baseline 